Data as of Mar 06
| -0.58 / -1.03%|
The 21 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 56.09, with a high estimate of 70.23 and a low estimate of 52.18. The median estimate represents a +0.43% increase from the last price of 55.85.
The current consensus among 28 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.